These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 14716760
1. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. De Vita F, Orditura M, Lieto E, Infusino S, Morgillo F, Martinelli E, Castellano P, Romano C, Ciardiello F, Catalano G, Pignatelli C, Galizia G. Cancer; 2004 Jan 15; 100(2):270-8. PubMed ID: 14716760 [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G. Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991 [Abstract] [Full Text] [Related]
3. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Tamesa T, Iizuka N, Mori N, Okada T, Takemoto N, Tangoku A, Oka M. Hepatogastroenterology; 2009 Jan 01; 56(93):1122-6. PubMed ID: 19760954 [Abstract] [Full Text] [Related]
4. Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG. Head Neck; 2002 Nov 01; 24(11):1004-11. PubMed ID: 12410536 [Abstract] [Full Text] [Related]
5. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Werther K, Christensen IJ, Brünner N, Nielsen HJ. Eur J Surg Oncol; 2000 Nov 01; 26(7):657-62. PubMed ID: 11078612 [Abstract] [Full Text] [Related]
6. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies. Poon RT, Lau C, Pang R, Ng KK, Yuen J, Fan ST. Ann Surg Oncol; 2007 Jun 01; 14(6):1835-45. PubMed ID: 17406950 [Abstract] [Full Text] [Related]
7. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Poon RT, Ho JW, Tong CS, Lau C, Ng IO, Fan ST. Br J Surg; 2004 Oct 01; 91(10):1354-60. PubMed ID: 15376182 [Abstract] [Full Text] [Related]
8. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. Poon RT, Lau C, Yu WC, Fan ST, Wong J. Oncol Rep; 2004 May 01; 11(5):1077-84. PubMed ID: 15069550 [Abstract] [Full Text] [Related]
17. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Cancer; 2005 Feb 15; 103(4):724-30. PubMed ID: 15637689 [Abstract] [Full Text] [Related]
18. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival. Chen CA, Cheng WF, Lee CN, Wei LH, Chu JS, Hsieh FJ, Hsieh CY. Gynecol Oncol; 2001 Feb 15; 80(2):207-12. PubMed ID: 11161861 [Abstract] [Full Text] [Related]
19. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Galizia G, Orditura M, Romano C, Lieto E, Castellano P, Pelosio L, Imperatore V, Catalano G, Pignatelli C, De Vita F. Clin Immunol; 2002 Feb 15; 102(2):169-78. PubMed ID: 11846459 [Abstract] [Full Text] [Related]